Marex Group’s Cardinal Health CAH Stock Holding History

Marex Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,500	Closed	-$308K	–	1046
2025 Q4	$308K	Sell	1,500 -500	-25%	-$94.1K	﹤0.01%	703
2025 Q3	$314K	Buy	+2,000	New	+$309K	﹤0.01%	613

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marex Group's CAH Position: Q3 2024 in Review

Marex Group sold out of Cardinal Health (CAH) in Q3 2024, closing a stake of 3,131 shares — an estimated $308K sold.

Marex Group first reported a position in CAH in Q4 2022 and held it in 3 quarters. The position peaked at $8.82M in Q4 2023. 1,015 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

Marex Group reported no remaining Cardinal Health position as of Q3 2024 after selling out during the quarter.
Marex Group sold 3,131 Cardinal Health shares in Q3 2024, an estimated $308K.
Marex Group first reported a position in Cardinal Health in Q4 2022 and held it in 3 quarters.
Marex Group's Cardinal Health position peaked at $8.82M in Q4 2023.
1,015 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Marex Group's 13F filing for Q3 2024, filed 7 Apr 2026.